SuRo Capital Corp. Third Quarter 2023 Preliminary Investment Portfolio Update
October 10, 2023 16:05 ET
|
SuRo Capital Corp.
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today provided the following preliminary update on its investment...
UMH PROPERTIES, INC. 2023 OPERATIONS UPDATE
October 02, 2023 17:00 ET
|
UMH Properties, Inc.
FREEHOLD, NJ, Oct. 02, 2023 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH), a real estate investment trust (REIT) specializing in the ownership and operation of manufactured home...
First Bank Announces Third Quarter 2023 Earnings Conference Call
September 28, 2023 09:15 ET
|
First Bank
HAMILTON, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company’s financial and operating performance...
Verano to Report Third Quarter 2023 Financial Results on November 8, 2023
September 26, 2023 07:30 ET
|
Verano Holdings Corp.
CHICAGO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to...
Nemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business Update
February 24, 2023 09:00 ET
|
Nemaura Medical, Inc
Loughborough, England, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
AMMO, Inc. Sets Fiscal Third Quarter 2023 Earnings Call
January 31, 2023 08:30 ET
|
AMMO, Inc.
SCOTTSDALE, Ariz., Jan. 31, 2023 (GLOBE NEWSWIRE) -- AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of GunBroker.com, the largest online marketplace serving the firearms and...
BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update
November 30, 2022 09:15 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Nov. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing, and commercializing innovative...